MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF 1) antagonist
The extrahypothalamic stress peptide corticotropin-releasing factor (CRF) system is an important regulator of behavioral responses to stress. Dysregulation of CRF and the CRF type 1 receptor (CRF 1) system is hypothesized to underlie many stress-related disorders. Modulation of the CRF 1 system by n...
Gespeichert in:
Veröffentlicht in: | Pharmacology, biochemistry and behavior biochemistry and behavior, 2008-02, Vol.88 (4), p.497-510 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The extrahypothalamic stress peptide corticotropin-releasing factor (CRF) system is an important regulator of behavioral responses to stress. Dysregulation of CRF and the CRF type 1 receptor (CRF
1) system is hypothesized to underlie many stress-related disorders. Modulation of the CRF
1 system by non-peptide antagonists currently is being explored as a therapeutic approach for anxiety disorders and alcohol dependence. Here, we describe a new, less hydrophilic (
cLogP ∼
2.95), small molecule, non-peptide CRF
1 antagonist with high affinity (
K
i
=
4.9 nM) and specificity for CRF
1 receptors:
N,
N-bis(2-methoxyethyl)-3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-pyrazolo[1,5-
a] pyrimidin-7-amine (MPZP). The compound was systemically administered to adult male rats in two behavioral models dependent on the CRF
1 system: defensive burying (0, 5, 20 mg/kg,
n
=
6–11 for each dose) and alcohol dependence (0, 5, 10, 20 mg/kg,
n
=
8 for each self-administration group). Acute administration of MPZP reduced burying behavior in the defensive burying model of active anxiety-like behavior. MPZP also attenuated withdrawal-induced excessive drinking in the self-administration model of alcohol dependence without affecting nondependent alcohol drinking or water consumption. The present findings support the proposed significance of the CRF
1 system in anxiety and alcohol dependence and introduce a promising new compound for further development in the treatment of alcohol dependence and stress-related disorders. |
---|---|
ISSN: | 0091-3057 1873-5177 |
DOI: | 10.1016/j.pbb.2007.10.008 |